ISO 24651:2022

Biotechnology — Biobanking — Requirements for human mesenchymal stromal cells derived from bone marrow

Biotechnology — Biobanking — Requirements for human mesenchymal stromal cells derived from bone marrow

Digital Document2022 edition2022Purchase Options

Referenced standards

ISO 20387:2018ISO 21709:2020ISO 8601-1
Unit Price
USD120.90Save 22%
USD 155.00

PREVIEW

ISO 24651:2022

Biotechnology — Biobanking — Requirements for human mesenchymal stromal cells derived from bone marrow

Biotechnology — Biobanking — Requirements for human mesenchymal stromal cells derived from bone marrow

This document specifies requirements for the biobanking of human mesenchymal stromal cells derived from bone marrow (hBM-MSCs), including the collection of bone marrow and associated data, isolation, culture, characterization, quality control, cryopreservation, storage, thawing, disposal, distribution and transport.

This document is applicable to all organizations performing biobanking with hBM-MSCs used for research.

This document does not apply to hBM-MSCs for the purpose of in vivo application in humans, cell therapy, clinical applications, tissue engineering or therapeutic use.

NOTE????? International, national or regional regulations or requirements, or multiple of them, can also apply to specific topics covered in this document.

Edition2022
Published Date2022
Published ByInternational Standardization Organisation
Page Count27